increlex

Generic: mecasermin

Labeler: ipsen biopharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name increlex
Generic Name mecasermin
Labeler ipsen biopharmaceuticals, inc.
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

mecasermin 40 mg/4mL

Manufacturer
Ipsen Biopharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 15054-1040
Product ID 15054-1040_21eb91ba-3cd8-47f0-a27b-35e3e5fd2e10
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA021839
Marketing Start 2006-01-03
Marketing End 2027-12-31

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 150541040
Hyphenated Format 15054-1040

Supplemental Identifiers

RxCUI
604806 615882
UNII
7GR9I2683O

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name increlex (source: ndc)
Generic Name mecasermin (source: ndc)
Application Number BLA021839 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/4mL
source: ndc
Packaging
  • 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE
source: ndc

Packages (1)

15054-1040-5 1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5) / 4 mL in 1 VIAL, MULTI-DOSE

Ingredients (1)

mecasermin (40 mg/4mL)

Linked Drug Pages (1)

Increlex ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "21eb91ba-3cd8-47f0-a27b-35e3e5fd2e10", "openfda": {"unii": ["7GR9I2683O"], "rxcui": ["604806", "615882"], "spl_set_id": ["a8b27a1b-a611-4f91-ad22-76d4b390c3ae"], "manufacturer_name": ["Ipsen Biopharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, MULTI-DOSE in 1 CARTON (15054-1040-5)  / 4 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "15054-1040-5", "marketing_end_date": "20271231", "marketing_start_date": "20060103"}], "brand_name": "Increlex", "product_id": "15054-1040_21eb91ba-3cd8-47f0-a27b-35e3e5fd2e10", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "15054-1040", "generic_name": "mecasermin", "labeler_name": "Ipsen Biopharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Increlex", "active_ingredients": [{"name": "MECASERMIN", "strength": "40 mg/4mL"}], "application_number": "BLA021839", "marketing_category": "BLA", "marketing_end_date": "20271231", "marketing_start_date": "20060103"}